Mitoxantrone is superior to liposomal daunorubicin in MRD (measurable residual disease)-guided treatment of AML in pediatric cases
1. Mitoxantrone enhances five-year event-free survival over liposomal daunorubicin in MRD-guided...
Read MoreApr 23, 2024
1. Mitoxantrone enhances five-year event-free survival over liposomal daunorubicin in MRD-guided...
Read MoreApr 23, 2024
1. The overall survival at 48 months was 91.2% in the pembrolizumab group vs 86.0% in the placebo...
Read MoreApr 19, 2024
BIO 300 use led to reduced levels of a proinflammatory/profibrotic cytokine associated with lung...
Read MoreApr 16, 2024
1. When compared to upfront surgery, neoadjuvant chemotherapy using mFOLFOX or CAPOX did not...
Read MoreApr 16, 2024
1. The hazard ratio for recurrence or death comparing sentinel node biopsy only to completion...
Read MoreApr 9, 2024
1. Roughly 65% of the cancer medication budget is allocated to treatments that provide improvement...
Read MoreApr 9, 2024
1. The pathological response rate had an OR of 3.16 when comparing neoadjuvant dual vs single...
Read MoreApr 3, 2024
1. 18-month recurrence-free survival was significantly greater in the combination therapy group...
Read MoreApr 2, 2024
1. Pazopanib did not improve disease-free survival in post-metastasectomy renal cell carcinoma...
Read MoreApr 2, 2024
1. The overall survival had a significant hazard ratio (0.65) when comparing neoadjuvant...
Read MoreMar 26, 2024
1. Invasive disease-free survival was significantly higher in patients receiving adjuvant...
Read MoreMar 26, 2024
1. VENICE-1 observed high response rates (complete or partial remission) in both BCRi-naïve and...
Read MoreMar 26, 2024
1. 83.1% of patients with confirmed colorectal cancer had a positive cfDNA test meeting the...
Read MoreMar 26, 2024
1. Adding chemotherapy to immunotherapy did not prolong OS or PFS, with non-significant...
Read MoreMar 23, 2024
1. There were similar rates of ipsilateral invasive recurrence among the postoperative adjuvant...
Read MoreMar 22, 2024
1. In this retrospective, population-based cohort study, adherence to health surveillance...
Read MoreMar 14, 2024
1. Significantly more patients in the imetelstat group achieved RBC transfusion independence at 8...
Read MoreMar 14, 2024
1. Amongst a cohort of breast cancer survivors, those that were treated with radiation had a...
Read MoreMar 8, 2024
1. In Ontario Canada, only 50% of home care clients received at least 1 or more palliative home...
Read MoreMar 7, 2024
1. Chinese patients with advanced cancer identified themes such as being treated as normal and...
Read More